ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,626.02
0.54%
US Tech 100
18,986.40
0.30%
Dow Jones
41,393.78
0.72%
Brent Oil
71.825
0.00%
Bitcoin
59,725.03
-1.41%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Cryptocurrencies
  4. COIN
  5. (Cryptocurrency:CPUEUR)

  6. (Cryptocurrency:CPUEUR) News

CPUEUR

(CPUEUR)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
09/14/20248:00AMBusiness WireUniversity of Phoenix Continues to Empower Young Learners at Hackathon Jr. Event
09/14/20247:43AMPR Newswire (US)Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
09/14/20247:30AMGlobeNewswire Inc.Medigene Presents Progress on KRAS Library and UniTope & TraCR Technology at ESMO 2024MDG1
09/14/20247:30AMPR Newswire (Canada)Prevost 100th Anniversary Celebration Culminates in Sainte-Claire
09/14/20247:30AMPR Newswire (Canada)Les célébrations du 100e anniversaire de Prevost culminent à Sainte-Claire
09/14/20247:11AMGlobeNewswire Inc.KFSHRC Revolutionizes Patient Care with Pioneering Experience Ambassadors Program
09/14/20247:00AMGlobeNewswire Inc.MADD Canada Holds Second Annual Ceremony for Ontario Victims of Impaired Driving
09/14/20247:00AMPR Newswire (Canada)Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)
09/14/20247:00AMPR Newswire (US)Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)
09/14/20246:52AMPR Newswire (US)Chengdu booming as global e-commerce hub
09/14/20246:30AMPR Newswire (Canada)L'opposition libérale presse le nouveau ministre d'agir maintenant et de mieux planifier pour régler la crise en francisation
09/14/20246:26AMPR Newswire (US)Sunwoda Inside at RE+ 2024: Showcasing Comprehensive Energy Storage Solutions Across the Full Industrial Chain
09/14/20246:00AMPR Newswire (Canada)Journée internationale de la démocratie - La FNCC-CSN rappelle l'importance des médias d'information
09/14/20245:22AMPR Newswire (US)Sineng Electric Expands U.S. Operations with New Service Center in Texas
09/14/20245:22AMPR Newswire (Canada)Sineng Electric Expands U.S. Operations with New Service Center in Texas
09/14/20245:18AMPR Newswire (US)Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
09/14/20245:00AMPR Newswire (US)Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development TimelinesNASDAQ:NUVLNuvalent Inc
09/14/20244:15AMBusiness WirePfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung CancerNYSE:PFEPfizer Inc
09/14/20244:15AMGlobeNewswire Inc.Cullinan Therapeutics Presents Positive Updated Data from Module C of Zipalertinib Pivotal Phase 2b Study at ESMO 2024NASDAQ:CGEMCullinan Therapeutics Inc
09/14/20244:06AMPR Newswire (US)Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
09/14/20244:00AMBusiness WireSVTA Announces New Board Officers
09/14/20244:00AMBusiness WireIrdeto Partners with Bitmovin to Deliver Industry-Leading Secure Low-Latency Streaming with Unmatched User Experience
09/14/20244:00AMPR Newswire (US)Inside Flagright: Our Approach to Hiring and Team Growth
09/14/20243:59AMBusiness WireSCFがニューパーク・フルード・システムズを買収NYSE:NRNewpark Resources Inc
09/14/20243:30AMGlobeNewswire Inc.Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024NASDAQ:BDTXBlack Diamond Therapeutics Inc
09/14/20243:15AMAlliance NewsAlliance NewsUS President Biden, UK PM Starmer put off Ukraine missiles decision
09/14/20243:15AMBusiness WireKEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy Significantly Improved Overall Survival (OS) Versus Trastuzumab and Chemotherapy Alone in First-Line Treatment of Patients With HER2-Positive Advanced Gastric or GEJ AdenocarcinomaNYSE:MRKMerck and Co Inc
09/14/20243:14AMAlliance NewsAlliance NewsHarris, Trump campaign in US battlegrounds as migrant row intensifies
09/14/20243:10AMAlliance NewsAlliance NewsTOP NEWS: China retail sales, industrial production slow in August
09/14/20243:10AMPR Newswire (US)RYBREVANT® (amivantamab-vmjw) plus chemotherapy shows positive overall survival trend versus chemotherapy in patients with previously treated EGFR-mutated lung cancerNYSE:JNJJohnson and Johnson

Your Recent History

USOTC
BCAP
Baron Capital Enterprise (CE)
USOTC
SPZI
Spooz (PK)
USOTC
CNNA
Cann American (CE)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
GNCP
GNCC Capital (CE)
USOTC
RDGL
Vivos (QB)
NASDAQ
DJT
Trump Media and Technology
USOTC
TONR
Tonner One World (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
DPLS
DarkPulse (PK)
COIN
BTCUSD
Bitcoin
USOTC
ITUP
Interups (CE)
USOTC
TXTM
ProText Mobility (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
ZHUD
Zhuding (PK)
USOTC
FNMA
Fannie Mae (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved